Dana-Farber/Boston Children's Cancer and Blood Disorders Center
2021
Boston
MA
Publications
Author Correction: A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas. View Abstract
H3K27M- and BRAF V600E-Altered gliomas and glioneuronal tumors-clinico-pathologic and radiologic perspective in a cohort treated with targeted therapy. View Abstract
Incidental Diffuse Midline Glioma, H3 K27-Altered of the Pons Without Significant Coalterations. View Abstract
Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure. View Abstract
Current Open Trials and Molecular Update for Pediatric Embryonal Tumors. View Abstract
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor. View Abstract
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics. View Abstract
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma. View Abstract
Molecular genetics of paediatric brain tumours and opportunities for precision medicine - a focus on infant tumours. View Abstract
Outcome of Benign Acute Childhood Myositis: The Experience of 2 Large Tertiary Care Pediatric Hospitals. View Abstract